Replies to post #179075 on Biotech Values

[DewDiligence]

RCPT—Will be interesting to see clinical trials data from other next generation S1P modulators, as there are differences between them regarding S1PR selectivity and potency and it remains to be determined which one has the best profile.

Which one(s) would you bet on if you had to place a bet?

[jq1234]

RCPT put key efficacy and safety data summary from several S1PR candidates currently in development at BOA presentation last month:

http://www.veracast.com/webcasts/baml/healthcare2014/events/1104_recept/pdf/Receptos_Inc.pdf